MXCT MaxCyte Inc shares fall 409 percent despite Q4 2025 EPS beat and doubledigit year over year revenue decline Is Cognizant CTSH stock showing recovery signs Q4 2025 Profit Surprises Vanguard SmallCap Index Admiral VSMAX Comprehensive Fund Analysis and Investment Outlook Frontier FNUC Stock Analyst Opinion Rocket Higher 20260415